Related Experiment Video
Updated: Jul 2, 2025

05:18
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
Published on: October 6, 2023
1.3K
Practice Patterns of Spatially Fractionated Radiation Therapy: A Clinical Practice Survey
Nina A Mayr1, Majid Mohiuddin2, James W Snider3
1College of Human Medicine, Michigan State University, East Lansing, Michigan.
Advances in Radiation Oncology
|February 26, 2024
Summary
Spatially fractionated radiation therapy (SFRT) is an accepted treatment for bulky tumors, with common palliative and curative approaches. However, SFRT-conventional external beam radiation therapy (cERT) sequencing and dosimetric parameter use show variability, indicating a need for standardization and further research.
Area of Science:
- Radiation Oncology
- Medical Physics
Background:
- Spatially fractionated radiation therapy (SFRT) is increasingly adopted for bulky advanced tumors.
- Clinical practice patterns for SFRT, including GRID and Lattice radiation therapy (LRT), require detailed understanding.
Purpose of the Study:
- To determine current practice patterns of GRID and Lattice radiation therapy (LRT)-based SFRT.
- To identify variations in patient selection, dosing, planning, and technique implementation.
Main Methods:
- A survey was distributed to radiation oncologists and physicists to gather data on SFRT practices.
- Data included patient selection, treatment parameters, combination therapies, and technical implementation.
- Descriptive statistics and permutation tests were used for data analysis.
Main Results:
- SFRT is considered a standard-of-care option by most radiation oncologists globally for bulky/advanced tumors.
- Commonly treated sites include head and neck, lung cancer, and sarcoma, for both palliative and curative intents.
- Significant variability exists in SFRT-conventional external beam radiation therapy (cERT) combination/sequencing and the clinical utilization of dosimetric parameters, with differences noted between GRID and LRT techniques.
Conclusions:
- SFRT has established itself as a clinical practice for advanced/bulky tumors with consistent major treatment approaches.
- Areas requiring attention include standardization of SFRT-cERT combinations/sequencing and clinical use of dosimetric parameters.
- Further research and targeted education are recommended to address identified inconsistencies and knowledge gaps.

